Solifenacin succinate/Tamsulosin hydrochloride Clonmel 6 mg/0.4 mg modified-release tablets

Indicated in the treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia (BPH) in men who are not adequately responding to treatment with monotherapy